Nirsevimab Administration and RSV Hospitalization in the 2024-2025 Season
Jonathan H. Pelletier(Children's Hospital of Pittsburgh), Christopher M. Horvat(University of Pittsburgh), Todd Karsies(Nationwide Children's Hospital), Michael T. Bigham(Akron Children's Hospital), Eric D. Robinette(Akron Children's Hospital), Sarah Rush(Akron Children's Hospital), Michael L. Forbes(Akron Children's Hospital), Steven L. Shein(Rainbow Babies & Children's Hospital), Danielle Maholtz(Akron Children's Hospital)
Cited by 7
Related Papers
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock
|JAMA|2024|202
Trends in US Pediatric Hospital Admissions in 2020 Compared With the Decade Before the COVID-19 Pandemic
|JAMA Network Open|2021|187
Artificial intelligence-based clinical decision support in pediatrics
|Pediatric Research|2022|162